You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pathologic Complete Response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

t Pathologic Complete Response Observed in HER2 Positive Breast

Completed
  • HER2+ Breast Cancer
  • Rawalpindi, Punjab, Pakistan
    Rawalpindi Medical University
Jun 26, 2023

Breast Cancer Trial (Omission of radiotherapy)

Not yet recruiting
  • Breast Cancer
  • Omission of radiotherapy
  • (no location specified)
Jun 8, 2022

Predictive Factor of Pathologic Complete Response After

Completed
  • Rectum Cancer
    • Bangkok, Bankok, Thailand
      Chairat Supsamutchai
    May 15, 2022

    Radiation OmisSion in PAtients With CLinically Node Negative

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      May 10, 2023

      Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

      Active, not recruiting
      • Esophageal Cancer
      • follow up
      • Guangzhou, Guangdong, China
        Jianhua Fu
      Sep 24, 2023

      Breast Cancer, HER2-positive Breast Cancer Trial in Los Angeles (Omit breast radiation)

      Not yet recruiting
      • Breast Cancer
      • HER2-positive Breast Cancer
      • Omit breast radiation
      • Los Angeles, California
        Cedars-Sinai Medical Center
      May 10, 2022

      Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

      Not yet recruiting
      • Anatomic Stage I Breast Cancer AJCC v8
      • +3 more
      • Pembrolizumab
      • +5 more
      • (no location specified)
      Apr 12, 2023

      Triple Negative Breast Cancer, Vitamin D Deficiency, Invasive Breast Cancer Trial in Winston-Salem (drug, dietary supplement,

      Recruiting
      • Triple Negative Breast Cancer
      • +2 more
      • Standard of Care Neoadjuvant Chemotherapy
      • +2 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Health Sciences
      Feb 8, 2022

      ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer

      Not yet recruiting
      • Rectal Cancer
      • Non Metastatic Rectal Cancer
      • ctDNA
      • Boston, Massachusetts
      • +1 more
      Nov 17, 2022

      Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

      Not yet recruiting
      • Esophageal Adenocarcinoma
      • +2 more
      • Palo Alto, California
      • +5 more
      Jan 12, 2023

      Breast Cancer Invasive Trial (Breast surgery omission)

      Not yet recruiting
      • Breast Cancer Invasive
      • Breast surgery omission
      • (no location specified)
      Aug 16, 2022

      Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

      Recruiting
      • Esophagus Adenocarcinoma
      • +2 more
      • Dallas, Texas
        Dallas VA Medical Center
      Nov 2, 2021

      Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

      Active, not recruiting
      • Anatomic Stage IIB Breast Cancer AJCC v8
      • +19 more
      • Gilbert, Arizona
      • +4 more
      Dec 6, 2022

      Rectal Cancer, Adenocarcinoma, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Madrid (neoadjuvant treatment)

      Completed
      • Rectal Cancer, Adenocarcinoma
      • +4 more
      • neoadjuvant treatment
      • Madrid, Spain
        Hospital La Princesa
      Aug 8, 2022

      Breast Cancer Trial in United States (MRI Biopsy)

      Recruiting
      • Breast Cancer
      • MRI Biopsy
      • Basking Ridge, New Jersey
      • +6 more
      Nov 23, 2022

      pCR After Neoadjuvant Therapy in Breast Cancer Patients

      Recruiting
      • Breast Cancer
      • TIL assessment in pre-existing histopathological specimens
      • Cairo, Egypt
        Faculty of Medicine, Ain Shams University
      Jul 25, 2022

      HER2-positive Breast Cancer Trial in Kansas City (Omission of Radiation)

      Recruiting
      • HER2-positive Breast Cancer
      • Omission of Radiation
      • Kansas City, Kansas
        University of Kansas Medical Center/ Cancer Center
      May 8, 2021

      After Neoadjuvant Chemotherapy for Breast Cancer

      Recruiting
      • TN ER-/PR-/HER2- Breast Cancer
      • +3 more
      • Standard Trimodality Breast Imaging
      • Minneapolis, Minnesota
        University of Minnesota Masonic Cancer Center
      Aug 13, 2021

      MRI Split Scar Sign asPredictor to Complete Pathologic Response

      Not yet recruiting
      • Rectum Cancer
      • total mesorectal excision
      • (no location specified)
      Feb 6, 2021

      MRI Based AI System to Predict pCR for Rectal Cancer

      Recruiting
      • Rectal Cancer
      • artificial intelligence prediction system
      • the radiologists
      • Guangzhou, Guangdong, China
      • +2 more
      Feb 19, 2021

      Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial in Seattle (drug,

      Terminated
      Has Results
      • Stage III Fallopian Tube Cancer
      • +14 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Dec 17, 2021

      Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)

      Recruiting
      • Melanoma Stage III
      • +2 more
      • Encorafenib Pill
      • +2 more
      • Tampa, Florida
        Moffitt Cancer Center
      May 27, 2022

      Breast Tumor Trial in Seoul (Minimally-invasive biopsy, wide excision)

      Completed
      Has Results
      • Breast Neoplasm
      • Minimally-invasive biopsy
      • wide excision
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 27, 2020

      Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

      Active, not recruiting
      • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 9, 2022

      Melanoma Trial in Rotterdam (Nivolumab)

      Recruiting
      • Melanoma
      • Rotterdam, Pending, Netherlands
        Erasmus MC
      Oct 30, 2023